Navigation Links
Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
Date:1/30/2008

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, as to financial guidance including realization of backlog, procedure growth, market acceptance, clinical studies, regulatory review and approval, and commercialization of products are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; variability of installation and sales cycle including customer financing and construction delays; competing products; the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for the 2007 fiscal year, as updated from time to time by our quarterly reports on Form 10-Q and our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.

Accuray Incorporated
'/>"/>

SOURCE Accuray Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Accuray Incorporated to Report Second Quarter Fiscal Year 2008 Financial Results
2. Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R) System
3. Accuray Reports Record Revenue in First Quarter of Fiscal 2008
4. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
5. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO 2007
6. Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
7. Accuray to Webcast Senior Management Presentations at Analyst Day Event
8. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
9. Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery
10. Cardinal Health Reports Second Quarter Results, Revises EPS Outlook
11. Encision Reports Third Fiscal Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... brain injury specialists look back on 40 years of the ... scale in research and clinical practice, in a new Personal ... , The Personal View is published on the 40th ... Lancet article*. Since this seminal publication, the Glasgow Coma ... impairment of conscious level, the clinical hallmark of acute brain ...
(Date:7/14/2014)... 2014 A recent study published in the July ... Academy of Child and Adolescent Psychiatry confirms the ... onset criterion for diagnosis of attention-deficit/hyperactivity disorder (ADHD). , ... set at 7 in DSM-IV, has been raised to ... now set at 12, rather than an earlier age, ...
(Date:7/14/2014)... the company Tissuegnostics, the pathologist Lukas Kenner and his ... identify cancer cells in tissue sections and demonstrate the ... provides a precise picture of the disease and leads ... the results of the study, "Two independent pathologists concur ... diagnosis." , "The recently developed software offers, for the ...
(Date:7/14/2014)... and Hauppauge, NY (PRWEB) July 14, 2014 ... (RGONY), with offices in Hicksville and Hauppauge, NY, ... implant) as a long-lasting treatment for diabetic macular ... Allergan, recently obtained an additional FDA-approved indication for ... approved by the FDA in 2009 for treatment ...
(Date:7/14/2014)... There’s an old adage that says first ... Palette say the products offered in their preorder event ... can reserve The Lash Palette for $40,” said Jenelle Paris, ... , Paris explained that the first 1,000 have already been ... She went on to point out that her company is ...
Breaking Medicine News(10 mins):Health News:Scientists developed new technology for the diagnosis of cancer cells 2Health News:Retina Group of New York Now Offers Long-lasting Ozurdex® Treatment for Diabetic Retinopathy 2Health News:Retina Group of New York Now Offers Long-lasting Ozurdex® Treatment for Diabetic Retinopathy 3Health News:The Lash Palette Preorder Event Has Officially Begun 2
... , , Improvement ... ROSEMONT, Ill., Aug. 3 A new study published in ... Joint Surgery (JBJS) finds that two years after anterior cervical ... can be expected to have significant improvement in their headache symptoms. , ...
... LOUIS, Aug. 3 Not just for teens anymore--social networking and ... by adults to interact with their friends, families and to gain ... these tools to the list of ways to interact with their ... its members like never before, Anthem Blue Cross and Blue Shield ...
... Hard to Treat Diseases, Inc. (HTDS:PK), http://www.htdsmedical.com ... division have reported results on experiments in which ... after traumatic brain injury have been explored. These ... the Hyperbaric Medical Center, School of Medicine, University ...
... The ... Harper, Jason Mraz, G. Love & others , ... Los Angeles, CA (PRWEB) August 3, 2009 -- Domestix, a Beverly Hills based domestic sales ... Thursday, August 6th at the Malibu Cinemas. "Domestix is thrilled to be involved with Jesse,s Story. ...
... PLAINSBORO, N.J., Aug. 3 Pharmacy & Healthcare Communications, LLC ... Pharmacy Times , a monthly journal that reaches the ... as well as its website, www.PharmacyTimes.com , ... custom supplements, including Pharmacy Times Careers ...
... By injecting man-made, microscopic tubes into tumors and heating ... have discovered a way to effectively kill kidney tumors in ... suggests a potential future cancer treatment for humans. The ... of the National Academy of Sciences ). It is the ...
Cached Medicine News:Health News:Neck Surgery for Cervical Spine Disorders Found to Alleviate Associated Headaches 2Health News:Neck Surgery for Cervical Spine Disorders Found to Alleviate Associated Headaches 3Health News:Anthem Blue Cross and Blue Shield in Missouri Harnesses Social Media to Interact with Members 2Health News:Anthem Blue Cross and Blue Shield in Missouri Harnesses Social Media to Interact with Members 3Health News:Hard to Treat Diseases, Inc. (HTDS) Experiments with Hyperbaric Oxygenation (HBO) Traumatic Brain Injury 2Health News:Hard to Treat Diseases, Inc. (HTDS) Experiments with Hyperbaric Oxygenation (HBO) Traumatic Brain Injury 3Health News:Hard to Treat Diseases, Inc. (HTDS) Experiments with Hyperbaric Oxygenation (HBO) Traumatic Brain Injury 4Health News:"Jesse's Story" to Open The 10th Annual Malibu Film Festival 2Health News:"Jesse's Story" to Open The 10th Annual Malibu Film Festival 3Health News:Pharmacy Times Names New Editorial Director 2Health News:Researchers effectively treat tumors with use of nanotubes 2Health News:Researchers effectively treat tumors with use of nanotubes 3
(Date:7/14/2014)... Ala. , July 14, 2014  Patients and ... patients as Express Scripts and other major pharmacy benefit ... The cuts will directly impact millions of patients who ... medical conditions, including persistent pain from cancer, diabetes and ... begin notifying some patients on July 15. ...
(Date:7/14/2014)... , 14 de julio de 2014 /PRNewswire-HISPANIC PR WIRE/ ... que Barry Epling , presidente de la junta ... de la Compañía. El señor Epling es el dueño ... otorgó la licencia de su formulación, sus propiedades intelectuales ... de apoyo financiero. "El señor Gerald ...
(Date:7/14/2014)... CITY , July 14, 2014  Remedy ... software for healthcare delivery and life sciences research, ... National Pancreas Foundation (NPF) to build the first-ever ... including pancreatic cancer and pancreatitis. "The ... the evolutionary change that thoughtful and committed organizations ...
Breaking Medicine Technology:Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 2Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 3Patients Join to Fight Major Cuts in Prescription Coverage Says Patients and Physicians for Rx Access 4BioAdaptives se prepara para el próximo paso 2BioAdaptives se prepara para el próximo paso 3Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 2Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 3
This double-up gel dryer system, 100-120 V, includes 2 Model 583 gel dryers, HydroTech™ vacuum pump, and double-up rack....
... GelAir™ drying system utilizes a hot air drying ... dried on a clear cellophane support for easy ... a smooth, flat assembly surface for the drying ... frames at once. This 115 V, 60 Hz ...
... is an electrophoresis gel vacuum dryer that removes ... these gels onto cellophane or filter paper for ... which heat gels from above. The drying surface ... unit includes power cord, porous gel support, transparent ...
... The PRO6000 power supply is ... power supply product offering. It ... and genomic electrophoresis. This product ... proteomic applications such as microAmp ...
Medicine Products: